| Financial Year |
March 31 2023 |
| Monetary Funds |
4,383,925,377.82 |
| Held-for-trading Financial Assets |
4,264,562,431.59 |
| Notes Receivable |
31,648,858.97 |
| Accounts Receivable |
877,052,126.38 |
| Advances to Suppliers |
238,121,498.36 |
| Other Receivables |
225,691,285.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,457,644,395.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
156,251,582.55 |
| Total Current Assets |
11,700,483,216.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,687,443.61 |
| Investment Properties |
8,469,804.11 |
| Fixed Assetes |
2,373,863,413.45 |
| Under-construction Projects |
819,598,127.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,016,922,875.57 |
| R&D expenses |
-- |
| Goodwill |
1,044,674,814.01 |
| Long-Term Deferred and Prepaid Expenses |
122,740,009.96 |
| Deferred Income Tax Assets |
317,785,715.99 |
| Other Non-Current Assets |
135,129,532.62 |
| Sub-Total of Non-Current Assets |
6,329,227,825.54 |
| Total Assets |
18,029,711,042.27 |
| Short-Term Loans |
2,423,356,166.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,760,000.00 |
| Accounts Payable |
847,891,987.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
181,501,685.05 |
| Taxes Payable |
189,823,091.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
462,262,271.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
171,077,406.43 |
| Other Current Liabilities |
23,969,454.82 |
| Sub-Total of Current Liabilities |
4,561,566,826.51 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
235,855,698.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
872,381,479.43 |
| Total Liabilities |
5,433,948,305.94 |
| Paid-In Capital(Or Share Stock) |
426,492,308.00 |
| Capital Surplus |
4,556,865,817.95 |
| Surplus Reserve |
420,212,778.13 |
| LESS:Treasury Stock |
500,082,734.11 |
| Undistributed Profits |
7,203,053,482.98 |
| Minority Stockholder's Interest |
488,855,531.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,106,907,204.88 |
| Owner's Equity（Stockholder's Equity） |
12,595,762,736.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,029,711,042.27 |
